http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106421746-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 2016-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106421746-B |
| titleOfInvention | The application of the salvage drug of cardiac arrest caused by [Pyr1] Apelin 13 is poisoned as long-acting local anesthetics of amide derivatives |
| abstract | The invention discloses one kind [Pyr 1 ] applications of the Apelin 13 as the salvage drug of cardiac arrest caused by the poisoning of long-acting local anesthetics of amide derivatives, its technical scheme is that the salvage drug includes [Pyr1] Apelin 13, is somebody's turn to do [Pyr1] Apelin 13 and is for peptide sequence：Glp‑Arg‑Pro‑Arg‑Leu‑Ser‑His‑Lys‑Gly‑Pro‑Met‑Pro‑Phe.The beneficial effects of the invention are as follows：The invention provides one kind to be based on [Pyr 1 ] Apelin 13 salvage drug, as can effectively save local anaesthetics poisoning caused by cardiac arrest, improve anabiosis rate.It is lower than generally acknowledged fat emulsion joint adrenaline use that this scheme adopts the secondary death rate, and 60 minutes survival rates are higher. |
| priorityDate | 2016-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 95.